Erratum to: FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells

被引：0
|
作者：
Juan Du
Lin Li
Zhouluo Ou
Chenfei Kong
Yu Zhang
Zhixiong Dong
Shan Zhu
Hao Jiang
Zhimin Shao
Baiqu Huang
Jun Lu
机构：
[1] Northeast Normal University,The Institute of Genetics and Cytology
[2] Fudan University,Department of Oncology, Breast Cancer Institute, Cancer Hospital, Shanghai Medical College
[3] Northeast Normal University,The Key Laboratory of Molecular Epigenetics of the Ministry of Education
来源：
Breast Cancer Research and Treatment | 2016年 / 156卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：609 / 610
页数：1
相关论文
共 50 条
  • [21] MIR-138-5P inhibits the progression of prostate cancer by targeting FOXC1
    Huang, Hui
    Xiong, Ying
    Wu, Zhensheng
    He, Yuhui
    Gao, Xianglin
    Zhou, Zhangyan
    Wang, Tao
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2020, 8 (04):
  • [22] FOXC1 is associated with estrogen receptor and affects sensitivity of tamoxifen treatment in breast cancer
    Wang, Jin-hua
    Xu, Ya-li
    Chen, Xiu-ping
    Li, Li
    Wang, Lin
    Yao, Ru
    Sun, Qiang
    Du, Guan-hua
    ACTA PHARMACOLOGICA SINICA, 2017, 38 (07) : 1079 - 1080
  • [23] FOXC1/FOXA1 transcriptional balance in breast cancer: From acquisition of mesenchymal and stem cell traits to occult lymph node independent breast cancer metastasis
    Ray, Partha S.
    Jensen, Tor W.
    Ray, Tania
    Gholamalamdari, Omid
    Tsai, Connie Y.
    Kim, Bomy
    Bhargava, Rohit
    Prasanth, K. V.
    CANCER RESEARCH, 2015, 75
  • [24] FGF19 is a target for FOXC1 regulation in ciliary body-derived cells
    Tamimi, Yahya
    Skarie, Jonathan M.
    Footz, Tim
    Berry, Fred B.
    Link, Brian A.
    Walter, Michael A.
    HUMAN MOLECULAR GENETICS, 2006, 15 (21) : 3229 - 3240
  • [25] Identification of Tgfβ1i4 as a downstream target of Foxc1
    Sommer, Paula
    Napier, Hugh R.
    Hogan, Brigid L.
    Kidson, Susan H.
    DEVELOPMENT GROWTH & DIFFERENTIATION, 2006, 48 (05) : 297 - 308
  • [26] Overexpression of FOXC1 Promotes Tumor Metastasis by Activating the Wnt/β-Catenin Signaling Pathway in Gastric Cancer
    Yang’an Sun
    Chao Lin
    Qunhua Ding
    Ying Dai
    Digestive Diseases and Sciences, 2022, 67 : 3742 - 3752
  • [27] FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer
    Ray, Partha S.
    Wang, Jinhua
    Qu, Ying
    Sim, Myung-Shin
    Shamonki, Jaime
    Bagaria, Sanjay P.
    Ye, Xing
    Liu, Bingya
    Elashoff, David
    Hoon, Dave S.
    Walter, Michael A.
    Martens, John W.
    Richardson, Andrea L.
    Giuliano, Armando E.
    Cui, Xiaojiang
    CANCER RESEARCH, 2010, 70 (10) : 3870 - 3876
  • [28] FOXC1 is a Critical Mediator of EGFR Function in Human Basal-like Breast Cancer
    Jin, Yanli
    Han, Bingchen
    Chen, Jiongyu
    Wiedemeyer, Ruprecht
    Orsulic, Sandra
    Bose, Shikha
    Zhang, Xiao
    Karlan, Beth Y.
    Giuliano, Armando E.
    Cui, Yukun
    Cui, Xiaojiang
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S758 - S766
  • [29] FOXC1 silencing inhibits the epithelial-to-mesenchymal transition of glioma cells: Involvement of -catenin signaling
    Cao, Qinchen
    Wang, Xinxin
    Shi, Yonggang
    Zhang, Mingzhi
    Yang, Jing
    Dong, Meilian
    Mi, Yin
    Zhang, Zhigang
    Liu, Ke
    Jiang, Li
    Wang, Na
    Wang, Ping
    MOLECULAR MEDICINE REPORTS, 2019, 19 (01) : 251 - 261
  • [30] MicroRNA-495/TGF-β/FOXC1 axis regulates multidrug resistance in metaplastic breast cancer cells
    Kumar, Uttom
    Hu, Yunhui
    Masrour, Nahal
    Castellanos-Uribe, Marcos
    Harrod, Alison
    May, Sean T.
    Ali, Simak
    Speirs, Valerie
    Coombes, R. Charles
    Yague, Ernesto
    BIOCHEMICAL PHARMACOLOGY, 2021, 192
12345